Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-7P stands for "RNA, U7 small nuclear 7 pseudogene," which is a **pseudogene** related to the U7 small nuclear RNA family. U7 small nuclear RNA (U7 snRNA) is a critical component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is required for the 3'-end processing of replication-dependent histone pre-mRNAs—an essential step in histone mRNA maturation in metazoans[2][3][4]. However, RNU7-7P itself is a **pseudogene**, meaning it is a non-functional sequence derived from the functional U7 snRNA gene, and generally does not produce an active RNA product or protein[3][4]. The functional U7 snRNA gene is important in biology, but **pseudogenes** like RNU7-7P are not involved in coding functional products, nor are they considered therapeutic targets. There are multiple RNU7-related pseudogenes in the human genome, and distinguishing functional U7 snRNA from pseudogenes is necessary for functional studies[3][4]. There is no evidence that RNU7-7P functions as a receptor, enzyme, transporter, or is targeted by drugs. If you are seeking a **therapeutic target** or functional gene, the correct entry would be the **functional U7 small nuclear RNA (U7 snRNA, RNU7-1 in humans)** rather than this pseudogene[2][3][4]. **Note:** - RNU7-7P is a pseudogene and thus not a functional molecular target or therapeutic entity. - It does not have known interacting drugs, established biological functions, disease roles, or biomarker status. - The entry is potentially misleading if intended as a functional target, as only the true U7 snRNA gene is biologically active.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 7 pseudogene (RNU7-7P).